AbsEn.i
Curation
Istex
Racine
Curation
Checkpoint
Istex
Racine
Istex
Exploration
Accueil
Racine
Racine

Serveur d'exploration MERS - Curation (Istex)

Index « AbsEn.i » - entrée « inhibition »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
inhibiting < inhibition < inhibitor  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 113.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000073 (2009) Lynn Pulliam [États-Unis]HIV Regulation of Amyloid Beta Production
000167 (1994) D. Archambault [Canada] ; C. A. Stein [États-Unis] ; J. S. Cohen [États-Unis]Phosphorothioate oligonucleotides inhibit the replication of lentiviruses and type D retroviruses, but not that of type C retroviruses
000188 (1992) E. J. Shillitoe [États-Unis] ; C. Steele [États-Unis]Inhibition of the Transformed Phenotype of Carcinoma Cells That Contain Human Papillomavirus
000215 (1995) Sang-Gug Kim [Japon] ; Toshifumi Hatta [Japon] ; Satoru Tsukahara [Japon] ; Hideki Nakashima [Japon] ; Naoki Yamamoto [Japon] ; Yoko Shoji [Japon] ; Kazuyuki Takai [Japon] ; Hiroshi Takaku [Japon]Antiviral effect of phosphorothioate oligodeoxyribonucleotides complementary to human immunodeficiency virus
000260 (1995) Z. Yao [République populaire de Chine] ; Y. Zhou [République populaire de Chine] ; A. Wang [République populaire de Chine] ; X. Bai [République populaire de Chine] ; W. Yang [République populaire de Chine]Inhibition of hepatitis B viral gene expression by antisense phosphorothioate oligodeoxynucleotides
000262 (1994) Diana L. Clark [États-Unis] ; Linda A. Chrisey [États-Unis] ; James R. Campbell [États-Unis, Égypte] ; Eugene A. Davidson [États-Unis]Non-sequence-specific antimalarial activity of oligodeoxynucleotides
000322 (1995) Carol Peterson [États-Unis] ; Christine C. Malone [États-Unis] ; Ralph C. Williams Jr [États-Unis]Rheumatoid-factor-reactive sites on CH3 established by overlapping 7-mer peptide epitope analysis
000323 (1996) J. G. Routsias ; A. G. Tzioufas [Grèce] ; M. Sakarellos-Daitsiotis ; C. Sakarellos ; H. M. Moutsopoulos [Grèce]Epitope mapping of the Ro/SSA60KD autoantigen reveals disease‐specific antibody‐binding profiles
000349 (2011) Marta De Zotti [Italie] ; Wim De Borggraeve [Belgique] ; Bernard Kaptein [Pays-Bas] ; Quirinus B. Broxterman [Pays-Bas] ; Sheo B. Singh [États-Unis] ; Peter J. Felock [États-Unis] ; Daria J. Hazuda [États-Unis] ; Fernando Formaggio [Italie] ; Claudio Toniolo [Italie]Triple Hyp→Pro replacement in integramide A, a peptaib inhibitor of HIV‐1 integrase: Effect on conformation and bioactivity
000390 (2004) Marcos Oggero [Argentine] ; Ronald Frank [Allemagne] ; Marina Etcheverrigaray [Argentine] ; Kratje [Argentine]Defining the antigenic structure of human GM-CSF and its implications for receptor interaction and therapeutic treatments
000398 (1991) Sudhir Agrawal [États-Unis] ; Prem S. Sarin [États-Unis]Antisense oligonucleotides: gene regulation and chemotherapy of AIDS
000440 (2004) Matthew D. Disney [États-Unis] ; Jessica L. Childs [États-Unis] ; Douglas H. Turner [États-Unis]New approaches to targeting RNA with oligonucleotides: Inhibition of group I intron self‐splicing
000498 (1995) Gerald Zon [États-Unis]Antisense phosphorothioate oligodeoxynucleotides: introductory concepts and possible molecular mechanisms of toxicity
000502 (1982) William M. Scovell [États-Unis] ; Lee R. Kroos [États-Unis]Cis-diamminedichloroplatinum(II) modification of SV40 DNA occurs preferentially in (G+C) rich regions: Implications into the mechanism of action
000504 (1988) Gerald Zon [États-Unis]Oligonucleotide Analogues as Potential Chemotherapeutic Agents
000507 (1990) Mark S. Urnes [États-Unis] ; Dana Carroll [États-Unis]Amylase synthesis as a simple model system for translation and hybrid arresst in Xenopus oocytes
000509 (1991) C. Boiziau [France] ; J. J. Toulmé [France]Modified oligonucleotides in rabbit reticulocytes: uptake, stability and antisense properties
000521 (1988) John Goodchild [États-Unis] ; Eddie Carroll Iii [États-Unis] ; Jay R. Greenberg [États-Unis]Inhibition of rabbit β-Globin synthesis by complementary oligonucleotides: Identification of mRNA sites sensitive to inhibition
000530 (2000) C. A Stein [États-Unis]Is irrelevant cleavage the price of antisense efficacy?
000548 (1998) Irma Colombo [Italie] ; Fabrizio Ceciliani [Italie] ; Severino Ronchi [Italie] ; Alberto Bartorelli [Italie] ; Bruno Berra [Italie]cDNA cloning and Escherichia coli expression of UK114 tumor antigen
000584 (2002) R. A. Heijtink [Pays-Bas] ; J. Kruining [Pays-Bas] ; P. Van Bergen [Pays-Bas] ; S. De Rave [Pays-Bas] ; J. Van Hattum [Pays-Bas] ; M. Schutten [Pays-Bas] ; A. D. M. E. Osterhaus [Pays-Bas]Characterization of a human monoclonal antibody obtained after immunization with plasma vaccine and a booster with recombinant‐DNA hepatitis B vaccine

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "inhibition" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "inhibition" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    inhibition
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021